Thematic Categories » 1. Health and Disease » 1.1. Geriatric disease-specific physical and mental conditions and multi-morbidity » 1.1.11. Neuropsychiatry

1.1.11.4. Dementia- Alzheimer and related diseases

Bibliographic Records

“Is Europe becoming more dementia friendly?” Yearbook 2015

Alzheimer Europe Yearbook 2015 Dementia in Europe Regular publication by the EU level NGO Alzheimer Europe on the situation in the MS

Mini Mental State Examination (MMSE): Determination of cutoff scores according to age and educational level

For the last 38 years, Mini Mental State Examination (MMSE) has been widely used as a dementia screening measure in everyday clinical practice as well as in both cohort and cross-sectional studies. Its validity and reliability for the Greek

Role of source memory and working memory in the precision of the self-testimony of older people

The aim of the study was to examine the relationship between working memory and source memory of older adult eye witness and the accuracy of their testimony. The effects of age and other individual-demographic factors on eyewitness testimony were also

Savion: An Interactive Cognitive Enhancement Software for the Elderly.

Non-pharmacological interventions are currently investigated as a means to enhance everyday cognitive and adaptive/social functioning. Computer-based programs afford greater ease and reduced cost of administration, features that are often critical for patient enrollment and compliance. Here we discuss potential advantages

A review of neuroimaging findings of apathy in Alzheimer’s Disease

There is a growing interest in the early diagnosis of apathetic older patients in the community since apathy has been associated with reduced daily functioning and caregiver distress. Longitudinal studies comparing patients and normal individuals might allow us to infer

Dementia and Older adults: Synchronous study in urban and semi-urban population

In Greece, given the demographic aging of the population, cognitive disturbances amongst older people, such as vascular dementia and Alzheimer’s disease, are a major public health problem, with the total cost of direct and indirect patient care amounting to 6